Company · Ownership research

Vir Biotechnology, Inc. VIR

CIK 0001706431

Form 4 transactions dated Nov 1, 2023 to Nov 9, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 36 rows; the complete set is available through the API.

Insider filings on file run through Nov 4, 2026.

Insider purchases & sales

Purchased: $0.00
Sold: $24.58M

Nov 1, 2023 – Nov 4, 2026
Available records · partial months are marked ·

202610 of 25 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Nov 3, 2026	de Verneuil Vanina EVP, General Counsel, Corp Sec	Sale10b5-1 footnote	$26.72K 2,407 shares sold	2.14% sold Direct holding	▾
Nov 2, 2026	de Verneuil Vanina EVP, General Counsel, Corp Sec	Sale10b5-1 footnote	$15.22K 1,343 shares sold	1.18% sold Direct holding	▾
Jun 1, 2026	Napolitano Janet Director	Sale10b5-1 footnote	$30.24K 3,200 shares sold	13.11% sold Direct holding	▾
Jun 1, 2026	Sabatini Brent SVP, Chief Accounting Officer	Sale10b5-1 footnote	$3.58K 379 shares sold	0.61% sold Direct holding	▾
May 1, 2026	SATO VICKI L Director	Sale10b5-1 footnote	$221.03K 22,000 shares sold	2.00% sold Direct holding	▾
Apr 6, 2026	De Backer Marianne President and CEO · Director	Sale10b5-1 footnote	$664.35K 72,559 shares sold	7.11% sold Direct holding	▾
Apr 1, 2026	SATO VICKI L Director	Sale10b5-1 footnote	$199.62K 22,000 shares sold	1.96% sold Direct holding	▾
Mar 23, 2026	Sabatini Brent SVP, Chief Accounting Officer	Sale10b5-1 footnote	$70.32K 7,711 shares sold	11.08% sold Direct holding	▾
Mar 2, 2026	SATO VICKI L Director	Sale10b5-1 footnote	$209.18K 22,000 shares sold	1.92% sold Direct holding	▾
Feb 25, 2026	Eisner Mark EVP and Chief Medical Officer	Sale10b5-1 footnote	$18.55K 1,889 shares sold	1.21% sold Direct holding	▾

Showing 25 / 25 record groups in 2026. The complete set is available through the API.

Vir Biotechnology, Inc. · VIR

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 25 of 25 purchase / sale groups and 30 of 36 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"VIR","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.